NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

10 hedge funds and large institutions have $365K invested in Northwest Biotherapeutics, Inc. Common stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MSAM
1
Moloney Securities Asset Management
Missouri
$251K

Top Sellers

1
AA
1
AlphaMark Advisors
Kentucky
$0
Name Market Value Shares Shares
Change 		Shares
Change %
MSAM
1
Moloney Securities Asset Management
Missouri
$251K 358,160 +5,500 +2%
OCG
2
Opus Capital Group
Ohio
$42K 60,150 – –
WJWM
3
Williams Jones Wealth Management
New York
$30.8K 44,000 – –
MCM
4
MAI Capital Management
Ohio
$14K 20,000 – –
LDB
5
Lee, Danner & Bass
Tennessee
$14K 20,000 – –
AMG
6
Advisors Management Group
Wisconsin
$7K 10,270 – –
BCWM
7
Bartlett & Co Wealth Management
Ohio
$3.15K 4,292 – –
BC
8
Bartlett & Co
Ohio
$3K 4,292 – –
AA
9
AlphaMark Advisors
Kentucky
– – -14,007 Closed
CMP
10
Coston McIsaac & Partners
Maine
$0 1,000 – –
HFS
11
Hantz Financial Services
Michigan
$0 250 – –